Current and past research projects

OBOE Research Environment

The OBOE Research Environment project was inaugurated in 2011 and is financially supported by VINNOVA. In the research environment we develop new therapy methods and tools in targeted applications related to cardiac rhythm, plastic surgery and drug screening. The center includes research groups from Linköping University, Karolinska Institutet and Acreo Swedish ICT together with AstraZeneca, St Jude Medical and Kratz Medical. The project also includes a clinical network that involves several groups from Karolinska Sjukhuset and the Faculty of Health Sciences at Linköping University.

Research:

  1. e-Ion Pumps
  2. e-Surfaces
  3. pe-Probes

Current and previous industrial partners of the project (also Kratz Medical):


Director. Magnus Berggren


OBOE Strategic Research Center

The Strategic Research Center project aimed at regulating and recording processes in cells, tissues and organs using organic electronic materials and devices. Through twinned research projects, spearheaded and performed by biologists and engineers, we developed new tools for the areas of cell signaling, stem cells and neuronal interconnects.

For instance:

  • Conducting polymer wires, “knitted” in to 2D networks hosting electrochemical transistors, are now being developed for novel neural interconnects.
  • Polyelectrolyte probes are presently being explored for in-vivo experiments.
  • Organic surface switch devices have been used to control the growth events of a range of different cell types.
  • The same surface switch devices also control the density of stem cells, which promises for electronic control of stem cell differentiation.
  • Electronic ion pumps have been developed to control cell signalling, targeting Ca 2+.

Management
Director: Magnus Berggren, ITN, LiU, magbe@itn.liu.se
Vice director: Agneta Richter-Dahlfors, Swedish Medical Nanoscience Center, KI, agneta.richter.dahlfors@ki.se
Administrator: Sophie Lindesvik, ITN, LiU, sopli@itn.liu.se
Administrator at KI: Margret Wahlström, Swedish Medical Nanoscience Center, KI, margret.wahlstrom@ki.se